Changing the paradigm: Elimination - Not only of cervical cancer.

Anal cancer HPV Human papillomavirus Oropharyngeal cancer Vulvar cancer

Journal

Gynecologic oncology reports
ISSN: 2352-5789
Titre abrégé: Gynecol Oncol Rep
Pays: Netherlands
ID NLM: 101652231

Informations de publication

Date de publication:
Aug 2024
Historique:
received: 27 04 2024
revised: 12 06 2024
accepted: 26 06 2024
medline: 24 7 2024
pubmed: 24 7 2024
entrez: 24 7 2024
Statut: epublish

Résumé

The WHO's initiative to eliminate cervical cancer by 2030 does not address the increasing incidence of vulvar, anal, and oropharyngeal cancers linked to high-risk HPV. Currently, the prevention of these three cancers faces various obstacles, such as a lack of specialized screening programs, well-defined management guidelines, and widespread public awareness. Without any interventions, the incidence of these three cancers will likely rise in the upcoming years, increasingly affecting younger individuals. We recommend expanding the WHO's initiative to include vulvar, anal, and oropharyngeal cancers. This involves developing screening and management protocols similar to those for cervical cancer, implementing gender-neutral HPV vaccination programs, establishing clear referral pathways to specialized centers, promoting public awareness, and providing education to healthcare providers and high-risk individuals.

Identifiants

pubmed: 39045263
doi: 10.1016/j.gore.2024.101445
pii: S2352-5789(24)00124-3
pmc: PMC11263942
doi:

Types de publication

Journal Article

Langues

eng

Pagination

101445

Informations de copyright

© 2024 The Author(s).

Déclaration de conflit d'intérêts

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Jacob Bornstein (J)

The Research Institute of Galilee Medical Center, Galilee Medical Center, Nahariya, Israel.
Department of Obstetrics and Gynecology, Azrieli Faculty of Medicine of Bar-Ilan University, Nahariya, Israel.

Koray Gorkem Sacinti (KG)

Department of Obstetrics and Gynecology, Ankara University School of Medicine, Ankara, Turkey.
Division of Epidemiology, Department of Public Health, Hacettepe University Faculty of Medicine, Ankara, Turkey.

Mario Preti (M)

Department of Surgical Sciences, University of Torino, Torino, Italy.

Salem Billan (S)

Department of Oncology and Radiation, Head and Neck Center, Rambam Health Care Campus, Israel Institute of Technology, Haifa 31096, Israel.

Hosna Razeghian (H)

Luigi Vanvitelli University of Campania School of Medicine and Surgery, Naples, Italy.

Colleen K Stockdale (CK)

Department of Obstetrics & Gynecology, University of Iowa, Iowa City, Iowa, USA.

Classifications MeSH